Daesung Microbiological Labs. Co. Ltd
Daesung Microbiological Labs. Co., Ltd. manufactures and sells vaccines for swine, poultry, canine, cattle, and fish in South Korea. It offers antibiotics and antibacterials, parasiticides and disinfectants, probiotics and enzyme products, and nutrients and pharmaceuticals. The company also exports its products. Daesung Microbiological Labs. Co., Ltd. was founded in 1966 and is headquartered in U… Read more
Daesung Microbiological Labs. Co. Ltd (036480) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.018x
Based on the latest financial reports, Daesung Microbiological Labs. Co. Ltd (036480) has a cash flow conversion efficiency ratio of -0.018x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-624.01 Million) by net assets (₩35.22 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Daesung Microbiological Labs. Co. Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Daesung Microbiological Labs. Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Daesung Microbiological Labs. Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Daesung Microbiological Labs. Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Yandal Resources Ltd
AU:YRL
|
-1.103x |
|
Asian Pac Holdings Bhd
KLSE:4057
|
0.066x |
|
China Green Agriculture Inc
NYSE:CGA
|
-0.025x |
|
Parkson Holdings Bhd
KLSE:5657
|
0.077x |
|
Groupe Partouche SA
PA:PARP
|
0.108x |
|
Kingsmen Resources Ltd
OTCQB:KNGRF
|
0.002x |
|
Grande Hospitality Real Estate Investment Trust
BK:GAHREIT
|
0.000x |
|
Wetteri
HE:WETTERI
|
0.085x |
Annual Cash Flow Conversion Efficiency for Daesung Microbiological Labs. Co. Ltd (2012–2024)
The table below shows the annual cash flow conversion efficiency of Daesung Microbiological Labs. Co. Ltd from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩35.15 Billion | ₩2.10 Billion | 0.060x | +281.12% |
| 2023-12-31 | ₩37.35 Billion | ₩-1.23 Billion | -0.033x | -211.04% |
| 2022-12-31 | ₩38.84 Billion | ₩1.16 Billion | 0.030x | -50.04% |
| 2021-12-31 | ₩37.00 Billion | ₩2.20 Billion | 0.060x | -33.19% |
| 2020-12-31 | ₩36.31 Billion | ₩3.24 Billion | 0.089x | +35.07% |
| 2019-12-31 | ₩35.09 Billion | ₩2.32 Billion | 0.066x | -30.56% |
| 2018-12-31 | ₩33.01 Billion | ₩3.14 Billion | 0.095x | +71.29% |
| 2017-12-31 | ₩30.30 Billion | ₩1.68 Billion | 0.055x | -54.29% |
| 2016-12-31 | ₩29.01 Billion | ₩3.52 Billion | 0.121x | -60.26% |
| 2015-12-31 | ₩25.09 Billion | ₩7.66 Billion | 0.305x | +68.35% |
| 2014-12-31 | ₩21.14 Billion | ₩3.83 Billion | 0.181x | +89.22% |
| 2013-12-31 | ₩19.72 Billion | ₩1.89 Billion | 0.096x | -18.93% |
| 2012-12-31 | ₩19.73 Billion | ₩2.33 Billion | 0.118x | -- |